Skip Navigation

Cardiovascular Research 1998 39(3):530-533; doi:10.1016/S0008-6363(98)00153-9
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Masaki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masaki, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

The discovery of endothelins

Tomoh Masaki

National Cardiovascular Center, Fujishirodai 5-7-1, Suita, Osaka 565, Japan

Received 18 March 1998; accepted 13 May 1998

The first 150 words of the full text of this article appear below.

It is generally accepted that the vascular endothelium is not a simple barrier between the blood stream and vascular bed. It has many functions in the regulation of vascular function that are mediated by various factors released from the endothelium which act on itself or other vascular cells in autocrine and paracrine manners. This concept emerged after the discovery of the endothelium-derived relaxing factor (EDRF) in 1980. The EDRF was later characterized as nitric oxide in 1987. Before the discovery of the EDRF, prostacycline was discovered, which is also a relaxing factor produced by the endothelium. These two relaxing factors are released from endothelial cells in response to a variety of vasoactive substances, and are thought to regulate vascular tone.

In contrast to endothelium-derived relaxing factors, less progress had been made in the field of endothelium-derived constricting factors such as thromboxane, a strong vasoconstrictor which is produced in the endothelium.

. . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Therapeutic Advances in GastroenterologyHome page
P. J. Troy and A. B. Waxman
Review: Portopulmonary hypertension: challenges in diagnosis and management
Therapeutic Advances in Gastroenterology, September 1, 2009; 2(5): 281 - 286.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
W. M Maharsy, L. N Kadi, N. G Issa, K. M Bitar, A. H Der-Boghossian, R. Abrahamian, and A. B Bikhazi
Cross-talk related to insulin and angiotensin II binding on myocardial remodelling in diabetic rat hearts
Journal of Renin-Angiotensin-Aldosterone System, June 1, 2007; 8(2): 59 - 65.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
J. Y. C. Tsang, W. J. E. Lamm, B. Neradilek, N. L. Polissar, and M. P. Hlastala
Endothelin receptor blockade does not improve hypoxemia following acute pulmonary thromboembolism
J Appl Physiol, February 1, 2007; 102(2): 762 - 771.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. A. Sarafidis and G. L. Bakris
Insulin and Endothelin: An Interplay Contributing to Hypertension Development?
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 379 - 385.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. S. Hassan, T. M. Williams, P. G. Frank, and M. P. Lisanti
Caveolin-1-deficient aortic smooth muscle cells show cell autonomous abnormalities in proliferation, migration, and endothelin-based signal transduction
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2393 - H2401.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
G. S. Hassan, S. Mukherjee, F. Nagajyothi, L. M. Weiss, S. B. Petkova, C. J. de Almeida, H. Huang, M. S. Desruisseaux, B. Bouzahzah, R. G. Pestell, et al.
Trypanosoma cruzi Infection Induces Proliferation of Vascular Smooth Muscle Cells
Infect. Immun., January 1, 2006; 74(1): 152 - 159.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. N. Channick, O. Sitbon, R. J. Barst, A. Manes, and L. J. Rubin
Endothelin receptor antagonists in pulmonary arterial hypertension
J. Am. Coll. Cardiol., June 16, 2004; 43(12_Suppl_S): 62S - 67S.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
N. Galie, A. Manes, and A. Branzi
The endothelin system in pulmonary arterial hypertension
Cardiovasc Res, February 1, 2004; 61(2): 227 - 237.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
N. H.S. Kim and L. J. Rubin
Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2002; 7(1): 9 - 19.
[Abstract] [PDF]


Home page
CirculationHome page
T. F. Luscher and M. Barton
Endothelins and Endothelin Receptor Antagonists : Therapeutic Considerations for a Novel Class of Cardiovascular Drugs
Circulation, November 7, 2000; 102(19): 2434 - 2440.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Barnes and A. J Turner
Endothelin converting enzyme is located on {alpha}-actin filaments in smooth muscle cells
Cardiovasc Res, June 1, 1999; 42(3): 814 - 822.
[Abstract] [Full Text] [PDF]